USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals mixed signals: strong growth in Hiya and Rise Wellness, but challenges with high tax rates and core business sales decline. The Q&A session highlights growth potential in new markets but lacks detailed insights, creating uncertainty. While the company's strategic initiatives and expansion plans are promising, concerns about profitability and financial uncertainty persist. Consequently, a neutral stock price movement is anticipated over the next two weeks, as positive growth prospects are balanced by financial and operational risks.
Key Financial Performance
Net Sales Net sales growth at the midpoint of about 4% for fiscal 2026. The growth is driven by venture companies, Rise Wellness and Hiya. Note that fiscal 2026 includes one less week of operations compared to fiscal 2025.
Inventory Inventories increased $35 million or 48% to $107 million at the end of fiscal 2025. Approximately 80% of the year-over-year increase was driven by initiatives to support significant growth opportunities at Rise Wellness and Hiya. For Rise Wellness, the increase reflects inventory necessary to support the launch and growth of Protein Pop, particularly at retailers like Costco. For Hiya, the increase reflects channel expansion, including distribution into Target, international expansion into Canada and the UK, and building raw materials inventory for in-house manufacturing.
Effective Tax Rate The effective tax rate for fiscal 2026 is expected to range between 55% and 60%. The high rate is due to a geographic misalignment between revenue generated and costs incurred, which was particularly evident in the second half of fiscal 2025. Execution of growth strategy and targeted cost efficiencies are expected to lower the effective tax rate in future years.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Product Innovation: USANA plans to advance its product innovation pipeline by leveraging its research and science teams to deliver differentiated offerings. This includes refreshed branding, alignment with modern consumer usage behaviors, and launching upgraded and new products globally in 2026.
Hiya Products: Hiya is expanding its product line and distribution channels, including entering Target, international markets like Canada and the UK, and transitioning to in-house manufacturing to improve margins.
Rise Wellness Products: Rise Wellness is scaling its performance by expanding the Rise Bar footprint and accelerating Protein Pop distribution, particularly within major retailers and club retail channels like Costco.
Omnichannel Expansion: USANA is expanding its omnichannel reach by diversifying distribution channels to access a larger global base of health-conscious consumers and strengthen brand relevance.
International Expansion: Hiya is expanding into international markets, including Canada and the UK, while Rise Wellness is focusing on major retailers and club retail channels.
Operational Efficiencies: USANA is focusing on disciplined cost management, streamlined processes, and transitioning to in-house manufacturing to increase speed, efficiency, and reduce costs.
Technology Modernization: USANA is accelerating its technology roadmap by adopting best-in-practice third-party platforms to improve customer experience and drive long-term IT and operational efficiencies.
Strategic Shift in Business Model: USANA is evolving from a legacy direct selling business to a modern science-driven nutritional products company, focusing on science-backed nutrition through an omnichannel platform.
Growth Strategy: USANA is reinvigorating global sales momentum through enhanced field support, market-specific strategies, and strengthened leadership engagement.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Economic and Operating Environment Uncertainty: Management highlighted uncertainty related to the global economic and operating environment, which could adversely impact operations and financial results.
Inventory Management Challenges: Inventories increased significantly by $35 million or 48%, driven by growth initiatives for Rise Wellness and Hiya. Elevated inventory levels are expected to persist, posing risks to working capital efficiency.
Geographic Revenue-Cost Misalignment: The company faces a geographic misalignment between revenue generated and costs incurred, leading to a high effective tax rate of 55%-60%, which could impact profitability.
Core Business Sales Decline: The core business has experienced year-over-year sales declines, although there are signs of stabilization. This poses a risk to overall revenue growth.
Technology Modernization Costs: The company plans to accelerate its technology roadmap, but the incremental investment required has not been factored into the fiscal 2026 outlook, creating potential financial uncertainty.
Expansion Risks for Hiya and Rise Wellness: Growth trajectories for Hiya and Rise Wellness involve significant inventory investments and expansion into new markets and channels, which could strain resources and operational efficiency.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Net Sales Growth: USANA projects consolidated net sales growth of 4% at the midpoint for fiscal 2026, driven by the performance of venture companies Rise Wellness and Hiya.
Technology Modernization: The company plans to accelerate its technology roadmap to enhance customer experience, scalability, and operational efficiency. However, the financial impact of this investment is not yet included in the fiscal 2026 outlook.
Inventory Levels: Elevated inventory levels are expected throughout fiscal 2026 to support growth opportunities for Rise Wellness and Hiya, including new product launches and channel expansions.
Rise Wellness Financial Performance: Rise Wellness is expected to operate at approximately breakeven in fiscal 2026 while positioning for future growth and profitability.
Effective Tax Rate: The effective income tax rate for fiscal 2026 is projected to range between 55% and 60%, with expectations for a lower rate in future years due to growth strategy execution and cost efficiencies.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you walk us through the different factors that would help achieve the top end of the revenue and EPS guidance?
A:Management highlighted the growth potential of key brands like Rise Wellness and Hiya, which are expanding into new markets such as Canada, the U.K., and Target stores in the U.S. They emphasized the importance of achieving top-line revenue to meet EPS targets. They also mentioned committed revenue from retailers like Target and Costco, and the potential for growth in the Protein Pop line and other new retailers.
Q:Is there anything to keep in mind regarding revenue seasonality throughout the year?
A:Management explained that seasonality is influenced by events like the Lunar New Year, which impacts promotional activity in markets like China. Q1 is typically stronger due to this, with momentum continuing into Q2. Q3 sees a lull due to vacations, while Q4 picks up as preparations for the next year begin.
Q:Can you provide additional insights into the growth of Hiya and Rise?
A:Hiya is performing well in Canada and is set to launch in the U.K. and Target stores. Rise is a growing brand, particularly with its Protein Pop line, which is gaining traction in the retail channel. However, specific numbers were not provided.
Q:How much did the cost realignment in Q4 reduce headcount, and what are the implications for gross margins and SG&A?
A:The cost realignment reduced the workforce by about 10%, resulting in approximately $10 million in savings. These savings are being repurposed into strategic initiatives, primarily affecting SG&A rather than gross margins. The mix of businesses, such as the thinner margins of Rise, will also impact financials.
Q:What are the plans for technology initiatives, and how impactful could they be?
A:Management aims to leverage technology to enhance brand interaction and relevance, focusing on speed to market and AI utilization. They plan to use external resources and expertise from brands like Hiya to improve brand awareness. The goal is to align with the health and wellness market's growth trajectory, which has a global CAGR of 5%-8%.
Q:What are your thoughts on integrating technology into the consumer health management journey?
A:Management is interested in using technology to personalize nutrition and move away from a one-size-fits-all approach. They are exploring partnerships to ensure scientific rigor and efficacy in health monitoring devices, focusing on both behavioral and physiological science.
Q:Review of Unclear Management Responses
A:Management avoided providing specific numbers or detailed insights for certain questions, such as the exact growth expectations for Hiya and Rise, and the specifics of technology initiatives. Their responses often included general optimism and high-level plans without concrete details.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Chairman
Chief Executive
Executive Officer
Hiya inventory
brand partner
capability
color outlook
confidence
cost efficiency
culture
discipline
distribution channel
expansion distribution
experience
focus
footprint
foundation
house
increase
launch
level
midpoint
nutrition
omnichannel
platform
priority
resilience
retailer
sale force
science product
speed
tax rate
technology
week
year
USNA Transcript
USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call Transcript
Unknown2-18
The earnings call reveals mixed signals: strong growth in Hiya and Rise Wellness, but challenges with high tax rates and core business sales decline. The Q&A session highlights growth potential in new markets but lacks detailed insights, creating uncertainty. While the company's strategic initiatives and expansion plans are promising, concerns about profitability and financial uncertainty persist. Consequently, a neutral stock price movement is anticipated over the next two weeks, as positive growth prospects are balanced by financial and operational risks.
USANA Health Sciences, Inc. (USNA) Q3 2025 Earnings Call Transcript
Unknown10-23
The earnings call highlights mixed signals: positive sales growth for Hiya and Rise Bar, promising trends from the new compensation plan, and strategic incentives planned for Q4. However, challenges include short-term margin pressures, potential operational disruptions from cost reductions, and uncertainties in supply chain transitions. The Q&A reveals management's confidence in growth, but lacks specifics on cost savings and Hiya's margin impact. Without clear guidance, the market may react cautiously, leading to a neutral stock price movement prediction.
USANA Health Sciences, Inc. (USNA) Q2 2025 Earnings Call Transcript
Positive7-23
The earnings call reveals strong financial performance, with debt repayment, robust growth in Hiya and Rise Bar, and a new partnership with Disney. The Q&A section addresses concerns about customer decline and tariffs, with management expressing optimism for future growth. The new incentive program and potential share buybacks are positive indicators. Despite some uncertainties, the overall sentiment is positive, suggesting a potential stock price increase of 2% to 8% over the next two weeks.
USANA at Sidoti Small-Cap Conference: Strategic Growth and Hiya Acquisition
Neutral3-20
USNA Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
